INVO Fertility (IVF) Cost of Revenue (2011 - 2026)

INVO Fertility (IVF) has 16 years of Cost of Revenue data on file, last reported at $1.3 million in Q1 2026.

• On a quarterly basis, Cost of Revenue rose 23.18% year-over-year to $1.3 million in Q1 2026; TTM through Mar 2026 was $4.5 million, a 18.09% increase from a year earlier, with the FY2024 full-year figure at $3.7 million, up 89.09% from the prior year.
• Cost of Revenue for Q1 2026 stood at $1.3 million, up from $1.1 million in the prior quarter.
• Over the last five years, Cost of Revenue for IVF reached as high as $1.3 million in Q1 2026 and fell as low as $64961.0 in Q1 2022.
• Historically, Cost of Revenue has averaged $678487.3 across 5 years, with a median of $855941.0 in 2024.
• On a YoY basis, Cost of Revenue climbed as much as 1302.01% in 2022 and fell as far as 7.7% in 2022.
• Year by year, Cost of Revenue stood at $234586.0 in 2022, then jumped by 278.01% to $886750.0 in 2023, then advanced by 7.97% to $957419.0 in 2024, then gained by 17.79% to $1.1 million in 2025, then advanced by 13.7% to $1.3 million in 2026.
• Per Business Quant data, the three most recent Cost of Revenue figures were $1.3 million in Q1 2026, $1.1 million in Q3 2025, and $1.1 million in Q2 2025.